Begrivac

País: Nova Zelândia

Língua: inglês

Origem: Medsafe (Medicines Safety Authority)

Ingredientes ativos:

Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15ug; Influenza virus haemagglutinin type A/New Caledonia/20/99 H1N1-like strain 15ug; Influenza virus haemagglutinin type B/Sichuan/379/99 - like strain 15ug

Disponível em:

Novartis New Zealand Ltd

DCI (Denominação Comum Internacional):

Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15 µg

Dosagem:

0.5 mL

Forma farmacêutica:

Suspension for injection

Composição:

Active: Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15ug Influenza virus haemagglutinin type A/New Caledonia/20/99 H1N1-like strain 15ug Influenza virus haemagglutinin type B/Sichuan/379/99 - like strain 15ug Excipient: Ether Formaldehyde Phosphate Buffered Saline Polymyxin B Polysorbate 80 Sucrose

Unidades em pacote:

Syringe, glass, Prefilled single 0.5ml dose, 1 dose unit

Classe:

Prescription

Tipo de prescrição:

Prescription

Fabricado por:

GSK Vaccines GmbH

Resumo do produto:

Package - Contents - Shelf Life: Syringe, glass, Prefilled single 0.5ml dose - 1 dose units - 12 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) - Syringe, glass, 0.5mL syringe, 10 pack - 10 dose units - 12 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Data de autorização:

1999-11-12